These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11363839)

  • 41. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
    Wilkins E
    J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
    [No Abstract]   [Full Text] [Related]  

  • 42. New treatment options.
    Fornataro K; Jefferys R
    Body Posit; 1999 Jun; 12(6):11-2. PubMed ID: 11367013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonnucleoside reverse transcriptase inhibitors.
    Murphy RL
    AIDS Clin Care; 1997 Oct; 9(10):75-7, 79. PubMed ID: 11364757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delavirdine available on expanded access.
    AIDS Treat News; 1996 Apr; (no 245):3. PubMed ID: 11363622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359.
    Gulick RM; Hu XJ; Fiscus SA; Fletcher CV; Haubrich R; Cheng H; Acosta E; Lagakos SW; Swanstrom R; Freimuth W; Snyder S; Mills C; Fischl M; Pettinelli C; Katzenstein D
    J Infect Dis; 2002 Sep; 186(5):626-33. PubMed ID: 12195349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NNRTIs: a neglected class.
    Cadman J
    GMHC Treat Issues; 1998 Sep; 12(9):6-10. PubMed ID: 11365807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors.
    Chetchotisakd P; Anunnatsiri S; Mootsikapun P; Kiertiburanakul S; Anekthananon T; Bowonwatanuwong C; Kowadisaiburana B; Supparatpinyo K; Ruxrungtham K;
    HIV Med; 2007 Nov; 8(8):529-35. PubMed ID: 17944686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delavirdine: clinical pharmacokinetics and drug interactions.
    Tran JQ; Gerber JG; Kerr BM
    Clin Pharmacokinet; 2001; 40(3):207-26. PubMed ID: 11327199
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A note about Viagra.
    Treat Rev; 1998; (No 28):15. PubMed ID: 11365423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Delavirdine (Rescriptor).
    Res Initiat Treat Action; 2000 Mar; 6(1):20-1. PubMed ID: 11708180
    [No Abstract]   [Full Text] [Related]  

  • 52. Standard treatments for HIV, Spring 1997.
    Smith D
    AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
    Schouten JT
    STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update from the 5th Conference on Retroviruses and Opportunistic Infections.
    Vazquez E
    Posit Aware; 1998; 9(3):21-3. PubMed ID: 11365483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fortovase approved: new saquinavir formulation.
    James JS
    AIDS Treat News; 1997 Nov; (No 283):1. PubMed ID: 11364907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The new antiretroviral arsenal.
    Smith D
    AIDS Treat News; 1996 Nov; (No 259):4-5. PubMed ID: 11364001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strategy update: protease-sparing regimens.
    Proj Inf Perspect; 1998 Dec; (26):14-5. PubMed ID: 11366490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ABT-378: Abbott "second generation" protease inhibitor.
    James JS
    AIDS Treat News; 1997 Feb; (No 265):6. PubMed ID: 11364243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
    TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
    [No Abstract]   [Full Text] [Related]  

  • 60. Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.
    Poirier JM; Guiard-Schmid JB; Meynard JL; Bonnard P; Zouai O; Lukiana T; Jaillon P; Girard PM; Pialoux G
    AIDS; 2006 Apr; 20(7):1087-9. PubMed ID: 16603872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.